Project Grant HT94252510894
Award Date 11/1/25
Completion Date 10/31/28
Dollars Obligated $2.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
- The Defense Health Agency awarded a $847,875 Project Grant to the Rector & Visitors of the University of Virginia (UVA) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "Targeting Schwann Cell-Tumor Microenvironment Interactions in Neurofibroma Development," supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The research project at UVA aims to investigate the cellular...
- The Project Grant award of $3,208,546.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports the expansion of the Generalized Blast Exposure Value Tool to determine cumulative blast exposure thresholds in military populations. The award was granted to the Rector & Visitors of the University of Virginia, a prominent public research university, on May 15, 2025, with a completion date of May 14, 2029. The goal of this research...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- The Defense Health Agency awarded a $1,592,860 Project Grant to the Rector & Visitors of the University of Virginia (UVA) on January 1, 2025 under the Military Medical Research and Development program (CFDA 12.420). The grant will support UVA's research to develop ultrasensitive proteomics techniques for predicting and assessing treatment efficacy for type 1 diabetes. This work aims to transform healthcare for military service members and the broader public by advancing innovative biomedical...
- The U.S. Defense Health Agency awarded a $5,540,949 Project Grant to the Rector & Visitors of the University of Virginia (UVA) to conduct research on focused ultrasound interventions for noninvasive precision therapy in primary and metastatic breast cancers. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The...
- This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
- This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...
- This $777,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting at the University of Wisconsin-Madison. The project aims to transform healthcare for military service members, veterans, and the broader public through advanced biomedical research. The 3-year project, commencing on June 1, 2025, will leverage the university's...
- This federal Project Grant award of $1,314,065.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research on the dose-response relationship of acute traumatic brain injury (TBI) blood biomarkers with pathoanatomic neuroimaging findings. The project will be conducted by the University of California, San Francisco (UCSF) over a period of 3 years from September 1, 2025 to August 31, 2028. The research...
- The Department of Defense's Defense Health Agency awarded a $2,728,777 Project Grant to the Rector & Visitors of the University of Virginia (UVA) under the Military Medical Research and Development (CFDA 12.420) program. The grant is for a research project titled "NEUROACTIVE STEROID BIOSYNTHESIS AND DYNAMIC GABAA RECEPTOR RECONFIGURATION IN POSTPARTUM DEPRESSION" with a performance period from May 1, 2025 to April 30, 2029. The project aims to conduct advanced biomedical...